Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

Volt Pharma Associates
Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202
Contact Volt Pharma Associates
Website

 Latest Content from PMHub 

The Evolving Role of the Sales Rep

White Papers and Resources | June 29, 2022 | Avalere Health

The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...

Measure your omnichannel maturity with our new tool

White Papers and Resources | June 29, 2022 | Avalere Health

Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness.

Report: Omnichannel advice for the life science industry

White Papers and Resources | June 29, 2022 | Avalere Health

In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...

Connect to the conversation around mental health: A spotlight on physician burnout

Press Releases | June 28, 2022 | Medscape Education

For more than 2 years, the COVID-19 pandemic has put emphasis on an issue that has long affected healthcare workers and physicians -- burnout. Every year, Medscape surveys thousands of...

Virtual MSL/Sales training programs and events

White Papers and Resources | June 27, 2022 | Impetus Digital

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

6 trends shaping the future of personalized medicine

White Papers and Resources | June 27, 2022 | Avalere Health

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

Omnichannel strategies to revolutionize the healthcare professional experience

White Papers and Resources | June 27, 2022 | Avalere Health

Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...

The digital-first launch: the key to connected stakeholder experiences?

White Papers and Resources | June 27, 2022 | Avalere Health

During the COVID-19 pandemic, a new digital-first launch model emerged as a gamechanger for driving better customer experiences. Here, Senior Consultant Srividya Sekar; Senior Associate Consultant, Erin Johnstone; and Associate...

Learning and development: the secret weapon for a successful life science launch

White Papers and Resources | June 26, 2022 | Avalere Health

Dave Stuteville, Executive Vice President, Learning & Development, reveals the principles behind successfully training Sales Representatives and Medical Science Liaisons for a rapid biopharmaceutical product launch.

Top 10 Benefits of Virtual Advisory Boards

Videos and Podcasts | June 23, 2022 | Impetus Digital

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...